<VariationArchive RecordType="classified" VariationID="3281" VariationName="NM_024529.5(CDC73):c.13_30del (p.Leu5_Gln10del)" VariationType="Deletion" Accession="VCV000003281" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-02-18" DateCreated="2016-11-18" MostRecentSubmission="2016-11-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18320" VariationID="3281">
      <GeneList>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+" />
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024529.5(CDC73):c.13_30del (p.Leu5_Gln10del)</Name>
      <CanonicalSPDI>NC_000001.11:193122211:GCTTAGCGTCCTGCGACAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122212" stop="193122229" display_start="193122212" display_stop="193122229" variantLength="18" positionVCF="193122211" referenceAlleleVCF="TGCTTAGCGTCCTGCGACA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091342" stop="193091359" display_start="193091342" display_stop="193091359" variantLength="18" positionVCF="193091341" referenceAlleleVCF="TGCTTAGCGTCCTGCGACA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>CDC73, 18-BP DEL, NT13</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.193091343_193091360del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.193091343_193091360del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.193122213_193122230del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.193122213_193122230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012691.1" sequenceAccession="NG_012691" sequenceVersion="1" change="g.5256_5273del">
            <Expression>NG_012691.1:g.5256_5273del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024529.5" sequenceAccession="NM_024529" sequenceVersion="5" change="c.13_30del" MANESelect="true">
            <Expression>NM_024529.5:c.13_30del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_078805.3" sequenceAccession="NP_078805" sequenceVersion="3" change="p.Leu5_Gln10del">
            <Expression>NP_078805.3:p.Leu5_Gln10del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_507" sequenceAccession="LRG_507">
            <Expression>LRG_507:g.5256_5273del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_507t1" sequenceAccession="LRG_507t1">
            <Expression>LRG_507t1:c.13_30del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_507p1" sequenceAccession="LRG_507p1" change="p.Leu5_Gln10del">
            <Expression>LRG_507p1:p.Leu5_Gln10del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252658" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607393.0015" DB="OMIM" />
        <XRef Type="rs" ID="587776561" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024529.5(CDC73):c.13_30del (p.Leu5_Gln10del) AND Parathyroid carcinoma" Accession="RCV000003442" Version="5">
        <ClassifiedConditionList TraitSetID="834">
          <ClassifiedCondition DB="MedGen" ID="C0687150">Parathyroid carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-11-18" MostRecentSubmission="2016-11-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15613436</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="834" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3270" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parathyroid carcinoma</ElementValue>
                <XRef ID="Parathyroid+carcinoma/5598" DB="Genetic Alliance" />
                <XRef ID="HP:0006780" DB="Human Phenotype Ontology" />
                <XRef ID="255037004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDC73-Related Parathyroid Carcinoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parathyroid cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parathyroid gland carcinoma</ElementValue>
                <XRef ID="MONDO:0012004" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRTC</ElementValue>
                <XRef Type="MIM" ID="608266" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7329" />
                <XRef ID="7329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="143" DB="Orphanet" />
              <XRef ID="C0687150" DB="MedGen" />
              <XRef ID="MONDO:0012004" DB="MONDO" />
              <XRef Type="MIM" ID="608266" DB="OMIM" />
              <XRef Type="primary" ID="HP:0006780" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23600" SubmissionDate="2016-11-16" DateLastUpdated="2016-11-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607393.0015_PARATHYROID CARCINOMA, SOMATIC" title="CDC73, 18-BP DEL, NT13_PARATHYROID CARCINOMA, SOMATIC" />
        <ClinVarAccession Accession="SCV000023600" DateUpdated="2016-11-18" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">See 607393.0013 and Moon et al. (2005).</Attribute>
              <Citation>
                <ID Source="PubMed">15613436</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDC73" />
          </GeneList>
          <Name>CDC73, 18-BP DEL, NT13</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">18-BP DEL, NT13</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607393.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARATHYROID CARCINOMA, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23600" TraitType="Disease" MappingType="Name" MappingValue="PARATHYROID CARCINOMA, SOMATIC" MappingRef="Preferred">
        <MedGen CUI="C0687150" Name="Parathyroid carcinoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

